A strong preference for the TA/TA dinucleotide step discovered for an acridine-based, potent antitumor dsDNA intercalator, C-1305: NMR-driven structural and sequence-specificity studies - Publication - Bridge of Knowledge

Your account

login

Search

A strong preference for the TA/TA dinucleotide step discovered for an acridine-based, potent antitumor dsDNA intercalator, C-1305: NMR-driven structural and sequence-specificity studies

Abstract

Triazoloacridinone C-1305, a potent antitumor agent recommended for Phase I clinical trials, exhibits high activity towards a wide range of experimental colon carcinomas, in many cases associated with complete tumor regression. C-1305 is a well-established dsDNA intercalator, yet no information on its mode of binding into DNA is available to date. Herein, we present the NMR-driven and MD-refined reconstruction of the 3D structures of the d(CGATATCG)2:C-1305 and d(CCCTAGGG)2:C-1305 non-covalent adducts. In both cases, the ligand intercalates at the TA/TA site, forming well-defined dsDNA:drug 1:1 mol/mol complexes. Orientation of the ligand within the binding site was unambiguously established by the DNA/ligand proton-proton NOE contacts. A subsequent, NMR-driven study of the sequence-specificity of C-1305 using a series of DNA duplexes, allowed us to confirm a strong preference towards TA/TA dinucleotide steps, followed by the TG/CA steps. Interestingly, no interaction at all was observed with duplexes containing exclusively the AT/AT, GG/CC and GA/TC steps.

Citations

  • 4

    CrossRef

  • 0

    Web of Science

  • 4

    Scopus

Authors (6)

Cite as

Full text

download paper
downloaded 18 times
Publication version
Accepted or Published Version
DOI:
Digital Object Identifier (open in new tab) 10.1038/s41598-020-68609-8
License
Creative Commons: CC-BY open in new tab

Keywords

Details

Category:
Articles
Type:
artykuły w czasopismach
Published in:
Scientific Reports no. 10,
ISSN: 2045-2322
Language:
English
Publication year:
2020
Bibliographic description:
Laskowski T., Andrałojć W., Grynda J., Gwarda P., Mazerski J., Gdaniec Z.: A strong preference for the TA/TA dinucleotide step discovered for an acridine-based, potent antitumor dsDNA intercalator, C-1305: NMR-driven structural and sequence-specificity studies// Scientific Reports -Vol. 10,iss. 1 (2020), s.11697-
DOI:
Digital Object Identifier (open in new tab) 10.1038/s41598-020-68609-8
Sources of funding:
  • Grant NCN 2017/01/X/NZ7/00752
Verified by:
Gdańsk University of Technology

seen 136 times

Recommended for you

C-1311 (Symadex), a potential anti-cancer drug, intercalates into DNA between A and G moieties. NMR-derived and MD-refined stereostructure of the d(GAGGCCTC) 2 :C-1311 complex

2017

Intercalation complex of imidazoacridinone C-1311, a potential anticancer drug, with DNA helix d(CGATCG)2: stereostructural studies by 2D NMR spectroscopy.

2016

Methods for Elucidation of DNA-Anticancer Drug Interactions and Their Applications in the Development of New Drugs

2016

The interactions of monomeric acridines and unsymmetrical bisacridines (UAs) with DNA duplexes: an insight provided by NMR and MD studies

2023
Meta Tags